Associations of plasma homocysteine level with brachial-ankle pulse wave velocity, LDL atherogenicity, and inflammation profile in healthy men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 2, 2011, Pages 136-143

  Yun, Jisuk ^a   Kim, Ji Young ^a   Kim, Oh Yoen ^a   Jang, Yangsoo ^b   Chae, Jey Sook ^a   Kwak, Jung Hyun ^a   Lim, Hyo Hee ^a   Park, Hyun Young ^c   Lee, Sang Hyun ^d   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea National Institute of Health   (South Korea)

^d National Health Insurance Corporation   (South Korea)

Author keywords

Brachial ankle pulse wave velocity; Homocysteine; Interleukin 1 ; LDL particle size; Oxidized LDL; TNF

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; ARTICLE; ASIAN; ATHEROSCLEROSIS; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION;

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE; VITAMIN B 12;

EID: 79451475985     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.08.003     Document Type: Article

References (41)

1. Stühlinger M.C., Oka R.K., Graf E.E., Schmölzer I., Upson B.M., Kapoor O., et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation 2003, 108:933-938.
2. Ruan L., Chen W., Srinivasan S.R., Xu J., Sun M., Toprak A., et al. Relation of plasma homocysteine to arterial stiffness in black and white young adults (from the Bogalusa heart study). Am J Cardiol 2009, 103(7):985-988.
3. Van Popele N.M., Grobbee D.E., Bots M.L., Asmar R., Topouchian J., Reneman R.S., et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001, 32:454-460.
4. Oliver J.J., Webb D.J. Non-invasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003, 23:554-566.
5. DeLoach S.S., Townsend R.R. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 2008, 3(1):184-192.
6. Blacher J., Demuth K., Guerin A.P., Safar M.E., Moatti N., London G.M. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998, 18:535-541.
7. Tayama J., Munakata M., Yoshinaga K., Toyota T. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res 2006, 29(6):403-409.
8. Yasmin, Falzone R., Brown M.J. Determinants of arterial stiffness in offspring of families with essential hypertension. Am J Hypertens 2004, 17:292-298.
9. Woodside J.V., McMahon R., Gallagher A.M., Cran G.W., Boreham C.A., Murray L.J., et al. Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults. Atherosclerosis 2004, 177:337-344.
10. De Bree A., Mennen L.I., Zureik M., Ducros V., Guilland J.C., Nicolas J.P., et al. Homocysteine is not associated with arterial thickness and stiffness in healthy middle-aged French volunteers. Int J Cardiol 2006, 113:332-340.
11. Bautista L.E., Arenas I.A., Peñuela A., Martínez L.X. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 2002, 55:882-887.
12. Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007, 9:1941-1958.
13. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 2005, 6:27-36.
14. Hung C.S., Lin J.W., Hsu C.N., Chen H.M., Tsai R.Y., Chien Y.F., et al. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 2008 Sep 22, (Epub ahead of print).
15. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr 1987, 422:43-52.
16. Anan F., Masaki T., Umeno Y., Yonemochi H., Eshima N., Saikawa T., et al. Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients. Metabolism 2007, 56:1390-1395.
17. Spoelstra-De Man A.M., Smulders Y.M., Dekker J.M., Heine R.J., Bouter L.M., Nijpels G., et al. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: Hoorn study. J Intern Med 2005, 258:536-543.
18. Schnell O., Muhr D., Weiss M., Kirsch C.M., Haslbeck M., Tatsch K., et al. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin. J Diabetes Complicat 1997, 11(5):307-313.
19. Levy D., Hwang S.J., Kayalar A., Benjamin E.J., Vasan R.S., Parise H., et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham heart study. Circulation 2007, 115:3079-3085.
20. Sugawara J., Hayashi K., Yokoi T., Cortez-Cooper M.Y., DeVan A.E., Anton M.A., et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness?. J Hum Hypertens 2005, 19:401-406.
21. Takaki A., Ogawa H., Wakeyama T., Iwami T., Kimura M., Hadano Y., Matsuda S., et al. Carido-ankle vascular index is superior to branchial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008, 31:1347-1355.
22. Takaki A., Ogawa H., Wakeyama T., Iwami T., Kimura M., Hadano Y., et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007, 71:1710-1714.
23. Horinaka S., Yabe A., Yagi H., Ishimura K., Hara H., Iemua T., et al. Comparison of atherosclerotic indicators between cardio ankle vascular index and branchial ankle pulse wave velocity. Angiology 2008 Nov 17, [Epub ahead of print].
24. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943.
25. Nakano E., Taiwo F.A., Nugent D., Griffiths H.R., Aldred S., Paisi M., et al. Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system. J Lipid Res 2005, 46(3):484-493.
26. Wang G., Mao J.M., Wang X., Zhang F.C. Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes. Chin Med J (Engl) 2004 Nov, 117(11):1650-1654.
27. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994, 344:793-795.
28. Holvoet P., Jenny N.S., Schreiner P.J., Tracy R.P., Jacobs D.R. Multi-Ethnic Study of Atherosclerosis. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2007, 194:245-252.
29. Gazi I.F., Tsimihodimos V., Tselepis A.D., Elisaf M., Mikhailidis D.P. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther 2007, 7(1):53-72.
30. Verhoye E., Langlois M.R., Rietzchel E., De Buyzere M., Gillebert T., De Bacquer D., et al. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clin Chem Lab Med 2009, 47(2):128-137.
31. Liu M.L., Ylitalo K., Salonen R., Salonen J.T., Taskinen M.R. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 2004, 24:1492-1497.
32. O'Neal D.N., Dragicevic G., Rowley K.G., Ansari M.Z., Balazs N., Jenkins A., et al. A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb. Diabetes Care 2003, 26:199-205.
33. Song H.G., Kim E.J., Seo H.S., Kim S.H., Park C.G., Han S.W., et al. Relative contributions of different cardiovascular risk factors to significant arterial stiffness. Int J Cardiol 2008 Nov 26, [Epub ahead of print].
34. Tomiyama H., Yamashina A., Arai T., Hirose K., Koji Y., Chikamori T., et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003 Feb, 166(2):303-309.
35. Gori A.M., Corsi A.M., Fedi S., Gazzini A., Sofi F., Bartali B., et al. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 2005 Aug, 82(2):335-341.
36. Zhou Z., Connell M.C., MacEwan D.J. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 2007, 19(6):1238-1248.
37. Dalal S., Parkin S.M., Homer-Vanniasinkam S., Nicolaou A. Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann Clin Biochem 2003, 40:534-541.
38. Bogdanski P., Pupek-Musialik D., Dytfeld J., Lacinski M., Jablecka A., Jakubowski H. Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients. Biomed Pharmacother 2008, 62:360-365.
39. Holven K.B., Aukrust P., Retterstol K., Hagve T.A., Mørkrid L., Ose L., et al. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest 2006, 66:45-54.
40. Zhang L., Jin M., Hu X.S., Zhu J.H. Homocysteine stimulates nuclear factor kappaB activity and interleukin-6 expression in rat vascular smooth muscle cells. Cell Biol Int 2006, 30:592-597.
41. Dudman N.P. An alternative view of homocysteine. Lancet 1999, 354:2072-2074.